M&A Deal Summary |
|
|---|---|
| Date | 2009-11-03 |
| Target | Algonomics NV |
| Sector | Life Science |
| Buyer(s) | Lonza |
| Deal Type | Add-on Acquisition |
SEARCH BY
| Category | Company |
|---|---|
| Founded | 1897 |
| Sector | Life Science |
| Employees | 18,000 |
| Revenue | 6.6B CHF (2024) |
Lonza is a global company that focuses on the life sciences sector, offering products and services for the pharmaceutical, biotech, and nutrition markets. Their portfolio spans across biopharmaceutical development and manufacturing, consumer health, nutrition, microbial control solutions, and custom manufacturing of specialty chemicals. Lonza was founded in 1897 and is based in Basel, Switzerland.
| DEAL STATS | # |
|---|---|
| Overall | 4 of 12 |
| Sector: Life Science M&A | 3 of 6 |
| Type: Add-on Acquisition M&A Deals | 2 of 10 |
| Country: Belgium M&A | 2 of 2 |
| Year: 2009 M&A | 2 of 2 |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2009-10-22 |
Cilian AG
Münster, Germany Cilian AG is a small innovative biotechnology company which uses the abilities of ciliates, eukaryotic single-cell micro-organisms (specifically the strain Tetrahymena thermophila), for the production of therapeutic proteins and nutritional ingredients. |
Buy | - |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2010-01-01 |
Vivante GMP Solutions
Houston, Texas, United States Vivante GMP Solutions, Inc. is a custom manufacturing organization dedicated to producing GMP viral-based therapeutics. Vivante provides its clients with flexible, disposable, scalable viral-based GMP production knowledge and capabilities to convert early-stage production into robust and scalable therapeutic products for clinical and commercial use. |
Buy | - |
